Back to top
more

Encompass Health (EHC)

(Delayed Data from NYSE)

$103.53 USD

103.53
693,737

+1.62 (1.59%)

Updated Nov 7, 2024 04:00 PM ET

After-Market: $103.58 +0.05 (0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 23% (58 out of 251)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Chemed (CHE) Q3 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Chemed (CHE) delivered earnings and revenue surprises of 8.13% and 0.79%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

What's in the Cards for Encompass Health (EHC) in Q3 Earnings?

by Zacks Equity Research

Encompass Health's (EHC) Q3 results are likely to reflect improved inpatient volumes and bed additions, offset by higher operating expenses.

Encompass Health (EHC) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Encompass Health (EHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Should Value Investors Buy Encompass Health (EHC) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Tenet Healthcare (THC) Rides on Strong Patient Volumes, Buyouts

by Zacks Equity Research

Tenet Healthcare (THC) gains from expanding patient admissions, diversified treatment network, acquisitions and robust cash-generating abilities.

Shaun Pruitt headshot

Top Medical Stocks to Buy Amid Market Volatility

by Shaun Pruitt

While there is no guarantee that medical stocks will offer a hedge against market volatility, healthcare is essential even during economic uncertainty.

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why You Should Retain Universal Health (UHS) Stock Now

by Zacks Equity Research

Universal Health (UHS) benefits from improving patient volumes, sound segmental performance and a solid capital position.

Encompass Health (EHC) Up 41% in a Year: More Room for Growth?

by Zacks Equity Research

Encompass Health (EHC) is well-poised for growth on the back of growing revenues, an aging U.S. population, joint ventures and solid cash reserves.

Is Encompass Health (EHC) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Encompass Health (EHC) and Eton Pharmaceuticals, Inc. (ETON) have performed compared to their sector so far this year.

Is ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for OUSM

Tenet Healthcare (THC) & Oracle Unite to Improve Efficiency

by Zacks Equity Research

Tenet Healthcare (THC) collaborates with Oracle Cloud HCM to improve and automate human resources and payroll processes.

Encompass Health (EHC) Opens JV Hospital With Piedmont in Georgia

by Zacks Equity Research

The Rehabilitation Hospital of Columbus is Encompass Health's (EHC) sixth location in the state of Georgia.

Waters (WAT) Walk-Up Solutions Boost Bioprocess Development

by Zacks Equity Research

Waters (WAT) launches new bioprocess walk-up solutions, automating sample prep and analysis from any bioreactor.

Zacks Industry Outlook Highlights DaVita, Encompass Health, Option Care Health and RadNet

by Zacks Equity Research

DaVita, Encompass Health, Option Care Health and RadNet are part of the Zacks Industry Outlook article.

Factors That Make Molina Healthcare (MOH) an Attractive Bet Now

by Zacks Equity Research

Molina Healthcare (MOH) remains well-poised for growth on a growing customer base, acquisitions and solid cash reserves.

4 Stocks to Buy in a Booming Outpatient Home Health Industry

by Zacks Equity Research

Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, EHC, OPCH and RDNT are well-poised to gain.

Encompass Health (EHC) Up 2.9% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Encompass Health (EHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Humana (HUM) to Provide In-home Care With Primary Care Anywhere

by Zacks Equity Research

Humana (HUM) enhances its CenterWell brand with the launch of Primary Care Anywhere.

Should ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for OUSM

Humana (HUM) to Bring Enhanced Kidney Care to MA Members

by Zacks Equity Research

Humana (HUM) makes Interwell's extensive resources available to its MA members grappling with CKD and ESKD, and hence bring about better health outcomes for them.

Urmimala Biswas headshot

5 Lucrative PEG-Based GARP Stocks for Investors

by Urmimala Biswas

Here are the five stocks that meet our screening criteria - PRDO, EHC, OSK, HSBC and PHM.

Nilanjan Choudhury headshot

5 Growth Opportunities Thriving on Relative Price Strength

by Nilanjan Choudhury

HURN, EHC, RDY, BOOM and HWKN are five stocks with explosive relative price strength.

Here's Why Encompass Health (EHC) Stock is a Strong Buy Now

by Zacks Equity Research

Encompass Health's (EHC) focus on boosting the number of licensed beds and hospitals will likely enhance market density and build scale.

Universal Health (UHS) Gains From Solid Segmental Performance

by Zacks Equity Research

Universal Health (UHS) gains from the uptrend in revenue growth, which in turn, is derived from expanding patient volumes. A credible financial position drives its expansion endeavors.